California-based startup Exo is redefining medical imaging—replacing bulky machines with a handheld ultrasound device that plugs into a smartphone. Now, the company is reportedly raising a $100 million round, with Samsung eyeing a stake and potential partnership via its medical arm, Samsung Medison.
Exo’s device blends AI, silicon tech, and app-based workflows, allowing clinicians to scan organs like the lungs or heart and instantly share results. It’s already backed by giants like Intel, BlackRock, Sony, and RA Capital—and has raised over $320 million to date.
With a future where every smartphone could double as a diagnostic tool, Exo may not just disrupt imaging—it could redefine frontline care.